The FDA has granted AtriCure approval for its Synergy ablation device for use in treating patients with atrial fibrillation during open-heart procedures. The Synergy system is the first such device to have been cleared for atrial fibrillation therapy in the U.S.
AtriCure gets FDA OK for Synergy ablation system
SmartBrief Job Listings for Health Care
|Compliance and Ethics Director||
Sysmex America, Inc.
|Director, Site Quality Management||
|Palm Springs, CA|
|Compliance Officer-Medical Products||
W. L. Gore